Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPI1 | P60174 | 2/20 | 0.48 |
| ▸ | PGD | P52209 | 3/20 | 0.38 |
| ▸ | PGK1 | P00558 | 1/20 | 0.37 |
| ▸ | PGK2 | P07205 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5485133 | 0.84 | TPI1 (0.56) | TPI1PGDPGK1PGK2LPAR3 | |
| SCHEMBL1533804 | 0.82 | GABRR1 (0.35) | TPI1GABRR1KDM4ELMNA | |
| SCHEMBL27449368 | 0.81 | LMNA (0.34) | TPI1GABRR1KDM4ELMNA | |
| SCHEMBL11529930 | 0.79 | TPI1 (0.30) | TPI1GABRR1 | |
| SCHEMBL2474974 | 0.77 | TPI1 (0.50) | TPI1PGDPGK1PGK2LPAR3 | |
| SCHEMBL43277 | 0.77 | TPI1 (0.50) | TPI1PGDPGK1PGK2LPAR3 | |
| SCHEMBL28466527 | 0.75 | TPI1 (0.48) | TPI1PGDPGK1PGK2LPAR3 | |
| SCHEMBL7059626 | 0.75 | TPI1 (0.48) | TPI1PGDPGK1PGK2LPAR3 | |
| SCHEMBL29156118 | 0.75 | TPI1 (0.48) | TPI1PGDPGK1PGK2LPAR3 | |
| Water SCHEMBL28701484 | 0.75 | TPI1 (0.48) | TPI1PGDPGK1PGK2LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011034263-A1 | METHOD FOR PREDICTING A DRUG TARGET IN PATHOGENIC MICROORGANISMS USING AN ESSENTIAL METABOLITE | 한국과학기술원 (KR) | 2011-03-24 | — | — | WO | claimed |
| WO-2011034397-A2 | METHOD FOR PREDICTING DRUG TARGETS AND SCREENING FOR DRUGS FOR PATHOGENIC MICROORGANISMS USING ESSENTIAL METABOLITES | 한국과학기술원 (KR) | 2011-03-24 | — | — | WO | claimed |
| US-20140162337-A1 | ISOPRENE PRODUCTION USING THE DXP AND MVA PATHWAY | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2014-06-12 | — | — | US | disclosed |
| US-8507235-B2 | Isoprene production using the DXP and MVA pathway | DANISCO US INC. (US) | 2013-08-13 | — | — | US | disclosed |
| EP-2443244-A1 | IMPROVED ISOPRENE PRODUCTION USING THE DXP AND MVA PATHWAY | Danisco US Inc. (US) | 2012-04-25 | — | — | EP | disclosed |
| WO-2011034263-A1 | METHOD FOR PREDICTING A DRUG TARGET IN PATHOGENIC MICROORGANISMS USING AN ESSENTIAL METABOLITE | 한국과학기술원 (KR) | 2011-03-24 | — | — | WO | disclosed |
| WO-2011034397-A2 | METHOD FOR PREDICTING DRUG TARGETS AND SCREENING FOR DRUGS FOR PATHOGENIC MICROORGANISMS USING ESSENTIAL METABOLITES | 한국과학기술원 (KR) | 2011-03-24 | — | — | WO | disclosed |
| US-20110014672-A1 | ISOPRENE PRODUCTION USING THE DXP AND MVA PATHWAY | THE GOODYEAR TIRE & RUBBER COMPANY | 2011-01-20 | — | — | US | disclosed |
| WO-2010148150-A1 | IMPROVED ISOPRENE PRODUCTION USING THE DXP AND MVA PATHWAY | DANISCO US INC. (US) | 2010-12-23 | — | — | WO | disclosed |
| EP-2230312-A1 | Probe compound for detecting and isolating enzymes and means and methods using the same | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2010-09-22 | — | — | EP | disclosed |
| US-20050164335-A1 | Methods and organisms for production of b6 vitamers | OMNIGENE BIOPRODUCTS, INC. | 2005-07-28 | — | — | US | disclosed |
| WO-2004035010-A2 | METHODS AND ORGANISMS FOR PRODUCTION OF B6 VITAMERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-04-29 | — | — | WO | disclosed |
| WO-2002068622-A2 | CRYSTAL STRUCTURE INFORMATION OF PNP SYNTHASE AND THE USE THEREOF | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN (DE) | 2002-09-06 | — | — | WO | disclosed |